Urticaria and angio-oedema due to ziprasidone

Simple item page
dc.contributor.buuauthorAkkaya, Cengiz
dc.contributor.buuauthorSarandöl, Aslı
dc.contributor.buuauthorAydoğan, Kenan
dc.contributor.buuauthorKirli, Selçuk
dc.contributor.departmentUludağ Üniversitesi/Tıp Fakültesi/Psikiyatri Anabilim Dalı.tr_TR
dc.contributor.departmentUludağ Üniversitesi/Tıp Fakültesi/Dermatoloji Anabilim Dalı.tr_TR
dc.contributor.scopusid14061855100tr_TR
dc.contributor.scopusid14020405100tr_TR
dc.contributor.scopusid9739755800tr_TR
dc.contributor.scopusid14019745700tr_TR
dc.date.accessioned2022-09-16T12:07:55Z
dc.date.available2022-09-16T12:07:55Z
dc.date.issued2007-07
dc.description.abstractAntipsychotic medications are commonly associated with adverse cutaneous reactions (ACRs) in approximately 5% of patients. Angio-oedema accompanying unticaria is one of the most serious ACRs. The 36-year-old female patient who was diagnosed with 'Paranoid schizophrenia' 6 years ago, was commenced on ziprasidone 120 mg/day. On day 30 of the treatment, the patient presented urticarial papules and plaques all over the body and angio-oedema in the face. The patient was diagnosed as 'Urticaria+Angio-oedema'. The development of ACRs after the initation of ziprasidone monotherapy, disappearance of Lesions after the discontinuation of this antipsychotic, and positive intradermal skin test all suggests a possible causal relationship between ACRs and ziprasidone. To our knowledge, this is the first reported case of unticaria and angio-oedema due to ziprasidone monotherapy. Ziprasidone is a valid and effective choice amongst antipsychotic medications, but this case calls for caution regarding ACRs at the time of prescribing.en_US
dc.identifier.citationAkkaya, C. vd. (2007). "Urticaria and angio-oedema due to ziprasidone". Journal of Psychopharmacology, 21(5), 550-552.en_US
dc.identifier.endpage552tr_TR
dc.identifier.issn1461-7285
dc.identifier.issn0269-8811
dc.identifier.issue5tr_TR
dc.identifier.pubmed17446198tr_TR
dc.identifier.scopus2-s2.0-34547124577tr_TR
dc.identifier.startpage550tr_TR
dc.identifier.urihttps://doi.org/10.1177/0269881106075273
dc.identifier.urihttps://journals.sagepub.com/doi/10.1177/0269881106075273
dc.identifier.urihttp://hdl.handle.net/11452/28790
dc.identifier.volume21tr_TR
dc.identifier.wos000248793200013tr_TR
dc.indexed.pubmedPubMeden_US
dc.indexed.scopusScopusen_US
dc.indexed.wosSCIEen_US
dc.language.isoenen_US
dc.publisherSage Publicationsen_US
dc.relation.journalJournal of Psychopharmacologyen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergitr_TR
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectAngio-oedemaen_US
dc.subjectAdverse cutaneous reactionsen_US
dc.subjectRisperidoneen_US
dc.subjectUrticariaen_US
dc.subjectZiprasidoneen_US
dc.subject.emtreeAdulten_US
dc.subject.emtreeBetamethasone sodium phosphateen_US
dc.subject.emtreeBiperidenen_US
dc.subject.emtreeFexofenadineen_US
dc.subject.emtreeHaloperidolen_US
dc.subject.emtreePheniramine maleateen_US
dc.subject.emtreeZiprasidoneen_US
dc.subject.emtreeZuclopenthixolen_US
dc.subject.emtreeArticleen_US
dc.subject.emtreePriority journalen_US
dc.subject.emtreeAngioneurotic edemaen_US
dc.subject.emtreeDrug withdrawalen_US
dc.subject.emtreePhysical examinationen_US
dc.subject.emtreeCase reporten_US
dc.subject.emtreeCausal attributionen_US
dc.subject.emtreeConsultationen_US
dc.subject.emtreeDermatologyen_US
dc.subject.emtreeDrug dose increaseen_US
dc.subject.emtreeFemaleen_US
dc.subject.emtreeParanoid schizophreniaen_US
dc.subject.emtreeFace edemaen_US
dc.subject.emtreeHumanen_US
dc.subject.emtreeMonotherapyen_US
dc.subject.emtreePapuleen_US
dc.subject.emtreeInvoluntary movementen_US
dc.subject.emtreeRigidityen_US
dc.subject.emtreeSide effecten_US
dc.subject.emtreeSingle drug doseen_US
dc.subject.emtreeSkin testen_US
dc.subject.emtreeSymptomen_US
dc.subject.emtreeUrticariaen_US
dc.subject.meshAntipsychotic agentsen_US
dc.subject.meshAdulten_US
dc.subject.meshAngioneurotic edemaen_US
dc.subject.meshFemaleen_US
dc.subject.meshHumansen_US
dc.subject.meshPiperazinesen_US
dc.subject.meshSchizophrenia, paranoiden_US
dc.subject.meshThiazolesen_US
dc.subject.meshUrticariaen_US
dc.subject.scopusDexamphetamine; Edema; Adrenergic Receptor Stimulating Agenten_US
dc.subject.wosClinical neurologyen_US
dc.subject.wosNeurosciencesen_US
dc.subject.wosPharmacology & pharmacyen_US
dc.subject.wosPsychiatryen_US
dc.titleUrticaria and angio-oedema due to ziprasidoneen_US
dc.typeArticle
dc.wos.quartileQ1en_US

Files

License bundle
Now showing 1 - 1 of 1
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description:
Download

Collections

Web of Science
PubMed
Scopus